European Neuropsychopharmacology
Volume 20, Issue 10 , Pages 671-675 , October 2010

The economic impact of depression: Resistance or severity?

  • L. Fostick

      Affiliations

    • Ariel University Center of Samaria, Israel
    • Corresponding Author InformationCorresponding author. Department of Communication Disorders, Ariel University Center of Samaria, 40700, Israel. Tel.: +972 3 9765776; fax: +972 3 9765743.
    • ,
  • A. Silberman

      Affiliations

    • Department of Psychiatry, Chaim Sheba Medical Center, Israel
    • ,
  • M. Beckman

      Affiliations

    • Ness-Ziona Mental Health Center, Israel
    • ,
  • B. Spivak

      Affiliations

    • Ness-Ziona Mental Health Center, Israel
    • ,
  • D. Amital

      Affiliations

    • Ness-Ziona Mental Health Center, Israel

Received 18 April 2010 ,Revised 3 June 2010 ,Accepted 9 June 2010.

References 

  1. Monthly Average Wage per Employee Job in 2005. Central Bureau of Statistics, press release no. 47/2006, March 8, 2006.
  2. Corey-Lisle PK, Birnbaum HG, Greenberg PE, Marynchenko MB, Claxton AJ. Identification of a claims data “signature” and economic consequences for treatment-resistant depression. J. Clin. Psychiatry. 2002;63(8):717–726
  3. Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, et al. The impact of treatment-resistant depression on health care utilization and costs. Clin. Psychiatry. 2002;63(11):963–971
  4. Fava M. Diagnosis and definition of treatment-resistant depression. Biol. Psychiatry. 2003;15(53(8)):649–659
  5. Fredman SJ, Fava M, Kienke AS, White CN, Nierenberg AA, Rosenbaum JF. Partial response, non-response, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current “next-step” practices. J. Clin. Psychiatry. 2000;61(6):403–408
  6. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J. Clin. Psychiatry. 1993;54(11):405–418
  7. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000?. J. Clin. Psychiatry. 2003;64(12):1465–1475
  8. Greenberg P, Corey-Lisle PK, Birnbaum H, Marynchenko M, Claxton A. Economic implications of treatment-resistant depression among employees. Pharmacoeconomics. 2004;22(6):363–373
  9. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  10. Joyce PR, Mulder RT, Luty SE, McKenzie JM, Sullivan PF, Abbott RM, et al. Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response. Aust. N. Z. J. Psychiatry. 2002;36(3):376–383
  11. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch. Gen. Psychiatry. 1999;56(7):617–626
  12. Kind P, Sorensen J. The costs of depression. Int. Clin. Psychopharmacol. 1993;7(3–4):191–195
  13. Kocsis JH. New strategies for treating chronic depression. J. Clin. Psychiatry. 2000;61(Suppl 11):42–45
  14. Ministry of Health published price list for ambulatory utilization and differential procedures, 2006.
  15. Nemeroff CB. Prevalence and management of treatment-resistant depression. J. Clin. Psychiatry. 2007;68(Suppl 8):17–25
  16. Russell JM, Hawkins K, Ozminkowski RJ, Orsini L, Crown WH, Kennedy S, et al. The cost consequences of treatment-resistant depression. J. Clin. Psychiatry. 2004;65(3):341–347
  17. Sackeim HA. The definition and meaning of treatment-resistant depression. J. Clin. Psychiatry. 2001;62(Suppl 16):10–17
  18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. 1998;59(Suppl 20):22–33
  19. Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O, et al. Treatment-resistant depression: methodological overview and operational criteria. Eur. Neuropsychopharmacol. 1999;9(1–2):83–91
  20. Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, et al. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J. Clin. Psychiatry. 2007;68(7):1062–1070
  21. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135–3144
  22. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant non-responders. J. Clin. Psychiatry. 1997;58(Suppl 13):23–29
  23. Thomas CM, Morris S. Cost of depression among adults in England in 2000. Br. J. Psychiatry. 2003;183:514–519
  24. Tierney JG. Treatment-resistant depression: managed care considerations. J. Manag. Care Pharm. 2007;13(6 Suppl A):S2–S7

PII: S0924-977X(10)00114-8

doi: 10.1016/j.euroneuro.2010.06.001

European Neuropsychopharmacology
Volume 20, Issue 10 , Pages 671-675 , October 2010

Article Tools